ObjectivesThe study objective was to review a single-center experience on robotic mitral valve repair to treat mitral regurgitation, with a specific focus on midterm echocardiographic mitral durability. No data assessing the quality or durability of repaired mitral valves are currently available.MethodsA total of 200 patients who underwent robotic mitral regurgitation repair using the da Vinci system (Intuitive Surgical, Inc, Sunnyvale, Calif) between August 2007 and December 2012 were evaluated. Serial echocardiographic results and operative and procedural times were analyzed.ResultsMitral regurgitation repairs were successfully performed, and no or mild residual mitral regurgitation developed in 98.0% of patients, with no conversion to st...
ObjectiveThe data on echocardiographic evaluation of mitral durability after rheumatic mitral repair...
ObjectivesMitral valve repair is the standard therapy for patients with degenerative (myxomatous) di...
ObjectiveIn a prospective phase II Food and Drug Administration trial, robotic mitral valve repairs ...
ObjectivesThe study objective was to review a single-center experience on robotic mitral valve repai...
ObjectiveWe sought to review the surgical outcomes of our initial 120 robotic mitral valve repairs f...
ObjectiveThe study objective was to review our first 300 consecutive robotic-assisted mitral repairs...
OBJECTIVES: We report the outcomes of robotic valve repair for degenerative mitral regurgitation (MR...
Background: We report the clinical and echocardiographic results of our experience in robotic mit...
Background: Mitral valve (MV) repair can now be carried out through small incisions with the use of ...
ObjectiveIn a prospective phase II Food and Drug Administration trial, robotic mitral valve repairs ...
Background:We report the clinical and echocardiographic results of our experiencein robotic mitral v...
BACKGROUND: To assess the safety and effectiveness, clinical experience with totally robotic mitral ...
ObjectiveWe sought to review the surgical outcomes of our initial 120 robotic mitral valve repairs f...
Background: Over the past two decades surgical approaches for mitral valve (MV) disease have evolved...
Background: Over the past two decades surgical approaches for mitral valve (MV) disease have evolved...
ObjectiveThe data on echocardiographic evaluation of mitral durability after rheumatic mitral repair...
ObjectivesMitral valve repair is the standard therapy for patients with degenerative (myxomatous) di...
ObjectiveIn a prospective phase II Food and Drug Administration trial, robotic mitral valve repairs ...
ObjectivesThe study objective was to review a single-center experience on robotic mitral valve repai...
ObjectiveWe sought to review the surgical outcomes of our initial 120 robotic mitral valve repairs f...
ObjectiveThe study objective was to review our first 300 consecutive robotic-assisted mitral repairs...
OBJECTIVES: We report the outcomes of robotic valve repair for degenerative mitral regurgitation (MR...
Background: We report the clinical and echocardiographic results of our experience in robotic mit...
Background: Mitral valve (MV) repair can now be carried out through small incisions with the use of ...
ObjectiveIn a prospective phase II Food and Drug Administration trial, robotic mitral valve repairs ...
Background:We report the clinical and echocardiographic results of our experiencein robotic mitral v...
BACKGROUND: To assess the safety and effectiveness, clinical experience with totally robotic mitral ...
ObjectiveWe sought to review the surgical outcomes of our initial 120 robotic mitral valve repairs f...
Background: Over the past two decades surgical approaches for mitral valve (MV) disease have evolved...
Background: Over the past two decades surgical approaches for mitral valve (MV) disease have evolved...
ObjectiveThe data on echocardiographic evaluation of mitral durability after rheumatic mitral repair...
ObjectivesMitral valve repair is the standard therapy for patients with degenerative (myxomatous) di...
ObjectiveIn a prospective phase II Food and Drug Administration trial, robotic mitral valve repairs ...